DiabetesGenetics
What this study is
This program collects genetic and health information to help doctors choose the right medications for patients.
Study details
- Official title
- The Texas Interprofessional Pharmacogenomics Registry and Repository
- Sponsor
- Texas A&M University
- Conditions
- Diabetes · Cholesterol · Cancer · Blood Pressure Disorders · Heart Disease · Respiratory Ilness · COPD · Adverse Drug Reaction (ADR) · Poly Pharmacy
- Enrolling
- 3,000 people
- Starts
- 2025-11
- Est. completion
- 2029-11
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- The study will invite patients who are eligible for PGX workup/PGX care to participate, provided they meet the following criteria: Use of five or more medications, including over the counter drugs, supplements, natural products, cannabis products, or other recreational drugs, or
- Individuals taking blood pressure or depression medications, even if less than five medications.
- Ability to understand and give consent.
- Able to consent to donate blood and/or urine samples and buccal swabs.
- Able to answer detailed questionnaires, including quarterly questionnaires about ADRs, cognitive testing such as serial mini-mental status exams, and or quality of life questions.
- Able to understand that their health record and changes in health status will be followed for a five-year period and shared in deidentified form with the research community.
- All genders.
- Any age over 18 years.
You can't join if
- Individuals admitted to hospice.
- Declines to participate or interact with staff/share their medical status.
- A diagnosis of Alzheimer's disease or related dementias in a medical record as this indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning.,
- Individuals who are unable or unwilling to provide consent.
- Unable to verbally communicate and comprehend English language
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openTexas A&M Family Care
Bryan, Texas, United States
- Sara Rogers, PharmD · Contact979.776.8440sararogers@tamu.edu
- Contactgneal@tamu.edu
- Kenneth S Kenneth S. Ramos, MD, PhD · Principal investigator
- Gabriel Neal, MD · Sub-investigator
- Sara Rogers, PharmD · Sub-investigator
- Rick Silva, PhD · Sub-investigator
- George Udeani, PharmD, DSC, FCP, FCCP · Sub-investigator
- Asim Abu-Baker, PharmD · Sub-investigator
- Fen Wang, PhD · Sub-investigator
- Marcia Ory, PhD · Sub-investigator
Recruiting
Study team
Sponsor
Texas A&M University
Study ID STUDY2023-0042
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.